Status:
UNKNOWN
Feasibility Study: The Effect of Prazosin for Nighttime Symptoms of Civilian PTSD
Lead Sponsor:
Rainier Associates
Conditions:
Stress Disorders, Post-Traumatic
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Investigating the effect of prazosin for nighttime symptoms of civilian Posttraumatic Stress Disorder.
Detailed Description
Each subject will receive prazosin and placebo trials, the order randomized. Day and nighttime symptoms will be monitored.
Eligibility Criteria
Inclusion
- must meet DSM-IV criterion for PTSD
Exclusion
- Must not have untreated sleep apnea
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00174551
Start Date
November 1 2003
End Date
November 1 2005
Last Update
September 11 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fletcher B. Taylor
Tacoma, Washington, United States, 98467